Bähr, O., Hattingen, E., Rieger, J., & Steinbach, J. P. (2011). Bevacizumab-induced tumor calcifications as a surrogate marker of outcome in patients with glioblastoma. Oxford University Press.
Stile di citazione ChicagoBähr, Oliver, Elke Hattingen, Johannes Rieger, e Joachim P. Steinbach. Bevacizumab-induced Tumor Calcifications As a Surrogate Marker of Outcome in Patients With Glioblastoma. Oxford University Press, 2011.
Citazione MLABähr, Oliver, Elke Hattingen, Johannes Rieger, e Joachim P. Steinbach. Bevacizumab-induced Tumor Calcifications As a Surrogate Marker of Outcome in Patients With Glioblastoma. Oxford University Press, 2011.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.